Ultrasonic Versus Conventional Clipping Hemostasis in Laparoscopic Colorectal Surgery
Launched by YONSEI UNIVERSITY · Aug 11, 2025
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different ways to control bleeding during minimally invasive surgery for colon cancer. One method uses an ultrasonic scalpel that seals blood vessels without clips for most vessels, while the other uses traditional metal clips to stop bleeding. The goal is to see which method is safer and more effective by looking at things like bleeding during and after surgery, the amount of fluid drained, and how long patients stay in the hospital.
Adults aged 19 to 80 with confirmed colon cancer who are generally healthy enough for surgery may be eligible to join. Participants will have laparoscopic surgery performed by experienced surgeons, and their care after surgery will be the same regardless of which method is used. The ultrasonic scalpel may reduce some risks linked to clips, such as infections or blockages, but clips will still be used for larger blood vessels if needed. If you join, you’ll be randomly assigned to one of the two methods, and the medical team won’t know which method you receive until after the surgery is done. This helps ensure the study is fair and reliable.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults 19 to 80 years of age
- • Patients with histologically confirmed pathologic adenocarcinoma of the colon
- • Patients with an ECOG score between 0 and 2
- • Patients with a preoperative ASA score of I to III
- • Patients without a history of surgery for abdominal malignancies
- • Patients with no history of anticoagulation prior to surgery
- • Patients who understand the study process and treatment plan and are able to complete the informed consent form themselves
- Exclusion Criteria:
- • Patients with an ASA score of 4 or higher
- • People with blood clotting disorders such as liver cirrhosis, end-stage renal failure, or hematologic disorders
- • Pregnant women
- • Mentally ill patients who have difficulty giving informed consent
- • Preoperative blood hemoglobin (Hb) less than 7 g/dL
- • Patients taking anticoagulants before or after surgery
- • Patients who have undergone emergency surgery
- • Patients who are unable to be followed up on an outpatient basi
- • No Informed consent
About Yonsei University
Yonsei University, a prestigious institution located in South Korea, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Yonsei University leverages its extensive expertise and innovative approaches in various fields of medicine to conduct rigorous clinical trials aimed at improving patient outcomes and advancing healthcare solutions. The university's robust infrastructure, multidisciplinary collaboration, and adherence to ethical standards ensure the integrity and reliability of its research initiatives, making it a key player in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported